Funded Tech Companies

Prime Medicine

Based in Cambridge, Prime Medicine raised its funding from GV, Moore Strategic Ventures and F-Prime Capital.

Company Overview

Contact Information

Company Background Information

Overview

Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can search and replace to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

7/14/2021

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Keith Gottesdiener

        

Chief Scientific Officer

Jeremy Duffield

        

Co-Founder

Andrew Anzalone

        

VP - General Counsel

Karen Brown

        

VP - Operations

Meredith Goldwasser

        

Company Investors

• GV (David Schenkein)
• Moore Strategic Ventures
• F-Prime Capital (Stephen Knight)
• Arch Venture Partners (Robert Nelsen)
• Samsara BioCapital
• Casdin Capital
• New Path Ventures
• Cormorant Asset Management
• PSP Investments
• Redmile Group

Browse more funded tech companies:

Prime Intellect | Prime Protocol

Share this article

About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary